[go: up one dir, main page]

WO2011027365A3 - Compositions ophtalmiques contenant du dorzolamide, du timolol et de la brimonidine - Google Patents

Compositions ophtalmiques contenant du dorzolamide, du timolol et de la brimonidine Download PDF

Info

Publication number
WO2011027365A3
WO2011027365A3 PCT/IN2010/000591 IN2010000591W WO2011027365A3 WO 2011027365 A3 WO2011027365 A3 WO 2011027365A3 IN 2010000591 W IN2010000591 W IN 2010000591W WO 2011027365 A3 WO2011027365 A3 WO 2011027365A3
Authority
WO
WIPO (PCT)
Prior art keywords
brimonidine
timolol
compositions containing
ophthalmic compositions
dorzolamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2010/000591
Other languages
English (en)
Other versions
WO2011027365A2 (fr
WO2011027365A9 (fr
Inventor
Rajesh Kshirsagar
Chandrashekar Kadam
Ajay Mhaske
Sm Mudda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Micro Labs Ltd
Original Assignee
Micro Labs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micro Labs Ltd filed Critical Micro Labs Ltd
Priority to RU2012113380/15A priority Critical patent/RU2012113380A/ru
Publication of WO2011027365A2 publication Critical patent/WO2011027365A2/fr
Publication of WO2011027365A9 publication Critical patent/WO2011027365A9/fr
Publication of WO2011027365A3 publication Critical patent/WO2011027365A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Wind Motors (AREA)

Abstract

La présente invention concerne une composition ophtalmique comprenant du timolol, du dorzolamide et de la brimonidine. Plus spécifiquement, la présente invention concerne une composition ophtalmique stable comprenant du timolol, du dorzolamide et de la brimonidine, y compris de l'hydroxyéthyl cellulose.
PCT/IN2010/000591 2009-09-07 2010-09-03 Compositions ophtalmiques contenant du dorzolamide, du timolol et de la brimonidine Ceased WO2011027365A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2012113380/15A RU2012113380A (ru) 2009-09-07 2010-09-03 Офтальмологические композиции, содержащие дорзоламид, тимолол и бримонидин

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2151CH2009 2009-09-07
IN2151/CHE/2009 2009-09-07

Publications (3)

Publication Number Publication Date
WO2011027365A2 WO2011027365A2 (fr) 2011-03-10
WO2011027365A9 WO2011027365A9 (fr) 2011-04-14
WO2011027365A3 true WO2011027365A3 (fr) 2011-06-23

Family

ID=43429374

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2010/000591 Ceased WO2011027365A2 (fr) 2009-09-07 2010-09-03 Compositions ophtalmiques contenant du dorzolamide, du timolol et de la brimonidine

Country Status (2)

Country Link
RU (1) RU2012113380A (fr)
WO (1) WO2011027365A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA030615B1 (ru) * 2013-12-24 2018-08-31 Сентисс Фарма Прайвет Лимитед Офтальмологический раствор бримонидина для местного применения
KR20180110113A (ko) * 2016-02-22 2018-10-08 산텐 세이야꾸 가부시키가이샤 도르졸라미드와 브리모니딘을 포함하는 의약 조성물

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008027340A2 (fr) * 2006-08-30 2008-03-06 Merck & Co., Inc. Formulations ophtalmiques locales
US20090048261A1 (en) * 2007-08-17 2009-02-19 Arturo Jimenez Bayardo Pharmaceutical Composition for Treatment of Ocular Hypertension
US20090069345A1 (en) * 2007-09-12 2009-03-12 Arturo Jimenez Bayardo Pharmaceutically Stable Compound Consisting of Timolol, Dorzolamide and Brimonidine

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008027340A2 (fr) * 2006-08-30 2008-03-06 Merck & Co., Inc. Formulations ophtalmiques locales
US20090048261A1 (en) * 2007-08-17 2009-02-19 Arturo Jimenez Bayardo Pharmaceutical Composition for Treatment of Ocular Hypertension
US20090069345A1 (en) * 2007-09-12 2009-03-12 Arturo Jimenez Bayardo Pharmaceutically Stable Compound Consisting of Timolol, Dorzolamide and Brimonidine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YEH ET AL.: "Rational use of the fixed combination of dorzolamide-timolol in the management of raised intraocular pressure and glaucoma", CLINICAL OPHTHALMOLOGY, vol. 2, no. 2, 1 January 2008 (2008-01-01), pages 389 - 399, XP002633634 *

Also Published As

Publication number Publication date
WO2011027365A2 (fr) 2011-03-10
WO2011027365A9 (fr) 2011-04-14
RU2012113380A (ru) 2013-10-20

Similar Documents

Publication Publication Date Title
MX2011012739A (es) Derivados fluorados de aminotriazol.
WO2010003133A3 (fr) Modulateurs de cdk
MY153880A (en) Proline derivatives as cathepsin inhibitors
WO2009077497A3 (fr) Azolylméthyloxiranes, utilisation de ceux-ci et agents contenant ceux-ci
MY153985A (en) Aminotriazole derivatives as alx agonists
MY153921A (en) Aminopyrazole derivatives
WO2010118866A8 (fr) Composition contenant du trehalulose, sa preparation et son utilisation
WO2009077443A3 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
WO2007093627A3 (fr) Composition biocide
WO2009077500A3 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
WO2010048358A3 (fr) Inhibiteurs à base d'éthoxyphénylméthyle de sglt2
WO2011017502A3 (fr) Formulations comprenant du linaclotide
HK1217489A1 (zh) Flap调节剂
WO2009089234A3 (fr) Dibenzhydrylpipérazines substituées
PH12014502696A1 (en) High water content oral compositions comprising microcrystalline cellulose and carboxymethylcellulose
IL189336A0 (en) Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization
CY1109865T1 (el) Συνθεσεις βαλσαρτανης
WO2008019030A3 (fr) Composés d'azole modifiés en tant qu'agents anti-infectieux
CL2012001736A1 (es) Composicion farmaceutica que comprende bimatoprost, brimonidina tartrato y timolol maleato; su uso para reducir la presión intraocular.
WO2011027365A3 (fr) Compositions ophtalmiques contenant du dorzolamide, du timolol et de la brimonidine
WO2012029074A3 (fr) Compositions pharmaceutiques de linézolide
WO2008098143A3 (fr) Composés antimicrobiens et leurs procédés d'utilisation
WO2010059639A3 (fr) Inhibiteurs à base d'hydroxyadamantyle de dipeptidylpeptidase iv
WO2010068717A3 (fr) Désactivateurs pyrazolinone de radicaux libres
AU2009249106A8 (en) Arylsulfonamide compounds, compositions and methods of use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10787199

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 12012500457

Country of ref document: PH

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2012113380

Country of ref document: RU

122 Ep: pct application non-entry in european phase

Ref document number: 10787199

Country of ref document: EP

Kind code of ref document: A2